Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted sulfonamides as selective .beta.-3 agonists for the treatment of diabetes and obesity

Substituted sulfonamides as selective .beta.-3 agonists for the treatment of diabetes and obesity

US Patent 5705515 · Granted Jan 6, 1998

Estimated economic value: $106,277,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AMPK activators2023
2′-alkynyl substituted nucleoside derivatives and methods of use thereof for the2017
Glucagon receptor antagonist compounds, compositions containing such compounds a2017
2-pyridinecarboxamide derivatives, compositions containing such compounds, and m2016
Glucokinase activator compounds, compositions containing such compounds, and met2016
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or2016
Soluble guanylate cyclase activators2016
Glucagon receptor antagonist compounds, compositions containing such compounds a2016
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of2016
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of2015
Dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes2015
Platelet-activating factor receptor antagonists2015